During the past decade, Osaka City General Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osaka City General Hospital" #1 collaborator was "Maruishi Pharmaceutical" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Osaka City General Hospital" are "Advanced Hepatocellular Carcinoma" (1 trials), "Conscious Sedation" (1 trials) and "NSCLC" (1 trials). Many other conditions were trialed in "Osaka City General Hospital" in a lesser frequency.

Most popular intervention types in "Osaka City General Hospital" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Dexmedetomidine" (1 trials), "Placebo" (1 trials), "Poziotinib Once Daily Dosing" (1 trials), "Poziotinib Once Daily Dosing or Twice Daily Dosing as determined in Phase 1" (1 trials) and "Poziotinib Twice Daily Dosing" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osaka City General Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Osaka City General Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Osaka City General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Osaka City General Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".